Suppr超能文献

[结直肠癌肝转移的重复肝切除术:23例经验]

[Repeated liver resections for metastases from colorectal carcinoma: the experience of 23 cases].

作者信息

Nicoli N, Marchiori L, Mangiante G, Bortolasi L, Dal Dosso I, Aurola P P, Delaini G G, Serio G

机构信息

Istituto di Patologia Chirurgica, Università degli Studi di Verona.

出版信息

Chir Ital. 1994;46(1):37-44.

PMID:8025969
Abstract

One hundred and thirteen patients with metastases from colorectal carcinoma underwent liver resection. The authors report their experience with respect to 23 repeated hepatic resections (or metastases from colorectal carcinoma). The calculated actuarial survival from the first operations is 100% at 12 months, 67% at 24 months, 48% at 36 months and 26% at 60 months. In 90 patients who underwent a single liver resection during the same period, 76% were alive at 12 months, 40% at 24 months, 27% at 36 months and 14% at 60 months (p = 0.03). Survivals calculated from the second operation were 67% at 12 months, 41% at 24 months and 11% at 35 months. There was no operative mortality with morbidity added to that of the first operation. None patients had extrahepatic disease at the second operation: this was resected. Seven patients were treated with neo adjuvant chemotherapy; six with systemic adjuvant chemotherapy; in one this was associated with loco-regional chemotherapy. The number of lesions (single versus multiple), the presence or absence of extrahepatic disease, neo-adjuvant chemotherapy and adjuvant chemotherapy did not seem to influence the prognosis. Average survival calculated from the appearance of the first metastasis in the liver is better in patients with a synchronous lesion compared to the patients with a metachronous lesion (48.1 months versus 29.3). The authors claim that surgery is indicated, when technically possible, in the hepatic recurrence of disease. The results are not as good as those obtained following the first liver resection, with a probability of earlier recurrence of disease.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

113例结直肠癌肝转移患者接受了肝切除术。作者报告了他们对23例重复肝切除术(或结直肠癌肝转移)的经验。首次手术计算得出的精算生存率在12个月时为100%,24个月时为67%,36个月时为48%,60个月时为26%。同期接受单次肝切除术的90例患者中,12个月时76%存活,24个月时40%存活,36个月时27%存活,60个月时14%存活(p = 0.03)。从第二次手术计算的生存率在12个月时为67%,24个月时为41%,35个月时为11%。没有手术死亡病例,其发病率与首次手术相加。第二次手术时没有患者有肝外疾病:均已切除。7例患者接受了新辅助化疗;6例接受了全身辅助化疗;其中1例联合了局部区域化疗。病灶数量(单发与多发)、肝外疾病的有无、新辅助化疗和辅助化疗似乎均不影响预后。与异时性病变患者相比,肝内首次转移灶出现时计算得出的同步性病变患者的平均生存期更好(48.1个月对29.3个月)。作者声称,在技术可行时,对于疾病的肝复发应行手术治疗。结果不如首次肝切除术后的结果好,疾病早期复发的可能性较大。(摘要截选于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验